PB1846: ALTERATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UPDATED PROSPECTIVE ANALYSIS.

por Stupakova, Z., Iryna, D., Zoya, M., Anna, S., Karnabeda, O., Melnyk, U., Novosad, O.
Publicado 2022

PB2283: COVID-19 (SARS-COV-2 INFECTION) IN LYMPHOMA PATIENTS

por Tytorenko, I., Kryachоk, I., Alexik, O., Kadnikova, T., Martynchik, A., Novosad, O., Pastyshenko, Y., Stepanishina, Y., Shokun, N., Filonenko, K.
Publicado 2022

PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP

por Filonenko, K., Kriachok, I., Martynchyk, A., Titorenko, I., Stepanishyna, Y., Aleksyk, O., Ukianchenko, K., Pastushenko, I., Kushchevyy, Y., Novosad, O., Karnabeda, O., Diagil, I., Kozlov, V.
Publicado 2022

PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA

por Novosad, O., Pastushenko, I., Kadnikova, T., Tytorenko, I., Martynchyk, A., Gorbach, O., Ashyhmin, A., Kmetyuk, Y., Karpova, O., Mykhalska, L., Kindrakevych, O., Novikov, M., Oliinichenko, O., Kriachok, I.
Publicado 2022